Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Compound Lysine Hydrochloride and Zinc Gluconate Granules

Approval Number

国药准字H20083017

Company海南慧谷药业有限公司

Registration Date

October 14, 2022

Previous Approval Numbers

国药准字H20083017

Drug Information

Generic Name

赖氨葡锌颗粒

Brand Name

巨可生

Dosage Form

颗粒剂(无糖)

Strength

盐酸赖氨酸125mg、葡萄糖酸锌35mg(相当于锌5mg)

Drug Type

化学药品

Registration Date

October 14, 2022

Company Information

Applicant Company

Company Name海南慧谷药业有限公司

Company Address

海口市美兰区顺达路16号

Manufacturing Company

Company Name海南慧谷药业有限公司

Company Address

海口市美兰区顺达路16号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy